News

The new laboratory, located in Chennai, will feature PerkinElmer’s advanced technologies for diagnosing common and serious health issues in expecting mothers and babies in India, including prenatal testing

The ESA APPRISE Oncology program will be launched on March 24, 2010. Direct patient registration or approval prior to ESA administration is not required through the ESA APPRISE

Temperature excursions can inhibit the clinical supply chain, resulting in investigational products being delayed or quarantined and not made available for immediate use at the study site. Excursions

Mederma stretch marks therapy is a patented formula that combines a blend of ingredients, including the proprietary botanical extract Cepalin, hyaluronic acid and centella asiatica leaf extract. Merz

The published study results further indicated the potential for the product in the treatment of ischemia- reperfusion injuries and in particular in the prevention of DGF following kidney

BiomeHT 90 has been tested in injection mouldings and sheet/thermoforming applications for use in many sectors and products, whilst also retaining the environmental credentials associated with Biome Bioplastics.

The new study was published in the current edition of Clinical Cancer Research, a journal of the American Association for cancer research. Seliciclib is currently in Phase 2

Medical device product sales decreased $1.3m to $2.7m and laboratory and scientific product sales decreased $200,000 to $654,000 for the three months ended December 31, 2009. Gross profit

Total revenue was $61.7m, up 84% from $33.5m on the comparable period last year. Revenue included $56.7m of Relenza royalties $1.4m of collaboration income from licensing agreements with